Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites

Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites

Background: Currently, hepatocellular carcinoma (HCC) patients with refractory ascites (RA) have a very poor prognosis, and there are no effective treatments recommended by the guidelines. A treatment strategy that utilizes a transjugular intrahepatic portosystemic shunt (TIPS) combined with subsequ...

Full description

Bibliographic Details
Main Authors: Huzheng Yan, Guobao Wang, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang, Fei Gao
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320303569

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320303569

Similar Items